MedPath

LOPINAVIR/RITONAVIR VIATRIS 200 MG/50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LOPINAVIR/RITONAVIR VIATRIS 200 MG/50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

1151067006

Prescription Type

Diagnóstico Hospitalario

Authorization Date

May 6, 2020

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1151067006
EMA Approved
Yes

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

LOPINAVIRActive
Quantity: 200.000 mg
Name: LOPINAVIR
RITONAVIRActive
Quantity: 50.000 mg
Name: RITONAVIR

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR10

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.